Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT02847468
What this trial is testing

Multimetabolic 18F-Fluorodeoxyglucose (FDG) and 18F-Fluorocholine (FCH) Positron Emission Tomography (PET) as an Early Predictive Factor of Overall Survival in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib

Who this might be right for
Carcinoma, Hepatocellular
Centre Georges Francois Leclerc 61
Testing effectiveness (Phase 2)Study completedNCT00712790
What this trial is testing

Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Singapore Clinical Research Institute 35
Not applicableUnknownNCT04996459
What this trial is testing

Tislelizumab in the Systematic Treatment of Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 40
Not applicableNot Yet RecruitingNCT06836518
What this trial is testing

Sialic Acid in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sohag University 100
Testing effectiveness (Phase 2)Looking for participantsNCT07337460
What this trial is testing

Efficacy and Safety of Icaritin Combined With mFOLFOX in Postoperative HCC With High-risk Recurrence Factors

Who this might be right for
Hepatocellular Carcinoma (HCC)
Northern Jiangsu People's Hospital 30
Not applicableNot Yet RecruitingNCT07707661
What this trial is testing

Application of Super-Resolution Ultrasound (SRUS) in Liver Tumor

Who this might be right for
Hepatocellular Carcinoma (HCC)Intrahepatic Cholangiocellular CarcinomaHepatic Hemangioma+2 more
Eastern Hepatobiliary Surgery Hospital 350
Early research (Phase 1)Ended earlyNCT04060342
What this trial is testing

GB1275 Monotherapy and in Combination With an Anti-PD1 Antibody in Patients With Specified Advanced Solid Tumors or in Combination With Standard of Care in Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic AdenocarcinomaEsophageal AdenocarcinomaEsophageal Squamous Cell Carcinoma+11 more
GB006, Inc., a wholly owned subsidiary of Gossamer Bio, Inc. 61
Not applicableUnknownNCT05458791
What this trial is testing

Intra-arterial Perfusion in Interventional Radiology

Who this might be right for
Hepatocellular Carcinoma
Palo Alto Veterans Institute for Research 20
Testing effectiveness (Phase 2)Looking for participantsNCT06852820
What this trial is testing

68Ga-PSMA-11 PET-directed Radioligand Therapy in Metastatic Hepatocellular Carcinoma (HCC)

Who this might be right for
Liver CancerHepatocellular CarcinomaMetastatic Liver Cancer
Melissa Lumish 10
Not applicableEnded earlyNCT05718882
What this trial is testing

Lenvatinib Plus VIC-1911 in Lenvatinib-unresponsive or Lenvatinib-resistant HCC

Who this might be right for
Liver CancerHepatocellular CarcinomaResistant Cancer
RenJi Hospital 5
Early research (Phase 1)UnknownNCT05675462
What this trial is testing

Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Fudan University 25
Testing effectiveness (Phase 2)Looking for participantsNCT05440708
What this trial is testing

TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tvardi Therapeutics, Incorporated 193
Testing effectiveness (Phase 2)Looking for participantsNCT05503797
What this trial is testing

Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Who this might be right for
Cancer Harboring BRAF AlterationsHGGLGG+1 more
Fore Biotherapeutics 254
Large-scale testing (Phase 3)UnknownNCT03851913
What this trial is testing

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Beyond Milan Criteria BCLC Stage A/B Hepatocellular Carcinoma Who Underwent Hepatectomy

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 344
Not applicableUnknownNCT06244446
What this trial is testing

Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.

Who this might be right for
Advanced Hepatocellular Carcinoma
Institute of Liver and Biliary Sciences, India 40
Not applicableLooking for participantsNCT06342440
What this trial is testing

Early Detection of Advanced Adenomas and Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal NeoplasmsColorectal Polyp+15 more
City of Hope Medical Center 2,000
Testing effectiveness (Phase 2)Study completedNCT00002842
What this trial is testing

Liver Resection and Floxuridine Plus Fluorouracil and Leucovorin in Treating Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
City of Hope Medical Center 49
Testing effectiveness (Phase 2)Ended earlyNCT04541173
What this trial is testing

Study of Atezolizumab and Bevacizumab With Y-90 TARE in Patients With Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Aiwu Ruth He, MD 6
Large-scale testing (Phase 3)Study completedNCT00241020
What this trial is testing

Evaluation of the Efficacy of Long-acting Release Octreotide in Patients With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular Carcinoma
Novartis Pharmaceuticals 270
Not applicableUnknownNCT04512846
What this trial is testing

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Who this might be right for
Large HCC PatientsStereotactic Body Radiation TherapyTranscatheter Arterial Chemoembolization
Beijing 302 Hospital 100
Next Page